SANUWAVE Health, Inc. (SNWV) Stock Price, Financials & Summary

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$4.15

From 52W high−88.85%

Volume86308.00

Market cap$39.14M

P/E (TTM)2.7x

P/S (TTM)0.9x

Div yield—

Key dataSep 18, 2026

Open

$4.15

From 52W high

−88.85%

Volume

86308.00

Market cap

$39.14M

ValuationView details →

P/E (Fwd)

6.1x

EV/EBITDA

2.6x

P/E (TTM)

2.7x

RSI (14)

39.5

MomentumView details →

1D Return

+10.17%

YTD Return

−85.39%

SummaryUpdated Jun 1, 2026

SANUWAVE Health, Inc. (NASDAQ:SNWV) is a medical device company founded in 2005 and headquartered in Suwanee, Georgia. The company specializes in developing and commercializing shock wave technology for regenerative medicine applications. SANUWAVE went public in 2009 and recently uplisted to NASDAQ in March 2025 after trading on lower exchanges. The company has transformed from a research-focused organization into a commercial-stage medical device manufacturer, experiencing significant revenue growth and expanding its market presence in wound care and other therapeutic applications.

Ask drillr about SANUWAVE Health, Inc. →

ValuationView details →

P/E (Fwd)

6.1x

P/E (TTM)

2.7x

EV/EBITDA

2.6x

EV/Sales

1.1x

P/S (TTM)

0.9x

P/B (TTM)

14.0x

ProfitabilityView details →

Gross Margin

75.20%

Net Margin

32.60%

EBITDA Margin

43.91%

ROE (TTM)

513.56%

ROA (TTM)

39.10%

Asset Turnover

1.19x

GrowthView details →

Revenue YoY

+12.02%

EPS YoY

+115.95%

FCF YoY

+5935.85%

Revenue CAGR 3Y

+38.05%

EPS CAGR 3Y

+119.63%

EBITDA YoY

+172.10%

MomentumView details →

1D Return

+10.17%

YTD Return

−85.39%

1Y Return

−87.50%

RSI (14)

39.5

vs 50D SMA

−22.49%

vs 200D SMA

−74.87%

Capital & dividendView details →

Debt/Equity

7.43x

Current Ratio

1.28x

Quick Ratio

0.89x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.08

EPS Surprise

−166.67%

Beats (12Q)

2/12

Next Q EPS Est

$0.01

Avg Surprise (4Q)

−56.67%

Rev Surprise

−15.31%

Financials snapshotView financials →

Revenue (TTM)

43.90M

Net Income (TTM)

14.31M

Op. CF (TTM)

5.22M

Next earningsNov 6, 2026 →

Latest newsMore news →

Sanuwave reported Q2 FY2026 financial results with revenues of $9.7 million, down 3% from $10.1 million in Q2 2025, and gross margin of 76.2% versus 78.1% in Q2 2025.45d ago

Similar companies

PAVmed Inc.PAVM QT Imaging Holdings, Inc.QTI InspireMD, Inc.NSPR Baird Medical Investment Holdings LimitedBDMD Inspira Technologies Oxy B.H.N. Ltd.IINN Sensus Healthcare, Inc.SRTS Find similar companies →

Latest newsMore news →

Sanuwave reported Q2 FY2026 financial results with revenues of $9.7 million, down 3% from $10.1 million in Q2 2025, and gross margin of 76.2% versus 78.1% in Q2 2025.45d ago